Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain

NCT00369785 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT00369785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00369785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2008
Completion date
July 1, 2012
Enrollment
198 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors, metastatic disease